Myomo price target raised to $4.60 from $2 at Alliance Global Partners

Alliance Global Partners analyst Ben Haynor raised the firm’s price target on Myomo to $4.60 from $2 and keeps a Buy rating on the shares following the Q3 beet. The firm says that given the recent favorable developments and the company’s strong Q3 performance, it is boosting the stock’s valuation multiple. It now has increased confidence in Myomo’s ultimate opportunity and expects the company’s growth to accelerate.